Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neurocrine Biosciences Inc (NASDAQ:NBIX)

42.93
Delayed Data
As of 3:59pm ET
 +1.29 / +3.10%
Today’s Change
34.68
Today|||52-Week Range
55.15
+10.93%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Revenue and IncomeNet Revenues15.0M0.000.000.00
 
 
Depreciation And Amortization276.0K324.0K408.0K492.0K
 
 
 
 
 
 
Operating ExpensesGross Income---324.0K-408.0K-492.0K
 
 
 
 
General Expenses35.6M41.5M38.0M45.8M
 
 
 
 
 
Research And Development23.9M26.9M20.9M22.6M
 
 
 
 
 
Total Operating Expenses35.9M41.8M38.4M46.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-20.9M-41.8M-38.4M-46.3M
 
 
 
 
 
Other Expenses856.0K868.0K844.0K863.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-19.3M-40.3M-36.9M-44.7M
 
 
 
 
 
Net Income-19.3M-40.3M-36.9M-44.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS86.5M86.7M86.8M86.9M
 
 
 
 
 
Shares To Calculate EPS Diluted86.5M86.7M86.8M86.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.22-$0.46-$0.43-$0.51
 
 
 
 
 
EPS Diluted-$0.22-$0.46-$0.43-$0.51